Pimm – Partial immortalization

A Biotech Geek (micro)Blogger’s adventures through science, technology and the web…

  • email me

    [attilacsordas][at][gmail.com]
  • Attila on Twitter

  • Recent Comments

    Matthew C. Kriner on How to isolate amniotic stem c…
    Srivichai on Google’s Palimpsest proj…
    tumamulet on Google Health, IBM: real-time,…
    wafflecheese on Aging-centric genetic health d…
    Ben on The marketing problem of life …
    Denise on Maximum Life CEO David Kekich:…
    goalranks on What does a good laboratory ho…
    goalranks on Google’s Palimpsest proj…
    sportza on Google’s Palimpsest proj…
    Campthree on How to read PDF files on iPhon…
  • licence

    Creative Commons License
  • c

  •  

    May 2008
    M T W T F S S
    « Apr   Jun »
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  

Archive for May 22nd, 2008

Life extension vs. overpopulation: which is overly popular?

Posted by attilachordash on May 22, 2008

Following the little Google trend watch on life extension, here is an interesting comparison complemented with a Google Fight:

and the fight: Read the rest of this entry »

Posted in google, life extension | 1 Comment »

Life extension on the web: stagnation or decline?

Posted by attilachordash on May 22, 2008

When Google Trends went live one of my first search was for “life extension” and posted a little analysis about that. Here is a quick update with a serious question about the stagnating or declining popularity of ‘life extension’ searches. Explanations are needed. /I don’t know the exact search scale for the y axis/.

Posted in google, life extension, partial immortalization | 2 Comments »

SciBX trial edition for May 22, 2008

Posted by attilachordash on May 22, 2008

from my mailbox:

Science-Business eXchange aka SciBX is a new publication from the makers of Nature and BioCentury that aims to improve the translation of today’s science into tomorrow’s products for the diagnosis, treatment and prevention of disease. Read the rest of this entry »

Posted in Nature Publishing Group, Natureplex, business 2.0, clinical trial, industry, journalism, science | Leave a Comment »